Monitoring methods

A - Human Necessities – 61 – B

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61B 10/00 (2006.01) G01N 33/74 (2006.01)

Patent

CA 2197388

A method of providing warning of the onset of the fertile phase of the human ovulation cycle, involving measurement in absolute or relative terms of the body fluid concentration of an analyte such as estradiol or a metabolite thereof wherein if in the current cycle a concentration measurement conducted at about the termination of menses reveals a body fluid concentration that is typical of that found in the body fluid of an average human female subject about 3 days prior to the time of ovulation during a 28-day cycle, the current cycle is immediately declared to be in its fertile phase. Where the analyte is E3G, the E3G concentration measurement is conducted on at least one or numerical days 4 to 7 of the current cycle, counting from the onset of menses, and the fertile phase is declared immediately if the E3G measurement reveals a concentration equal to or greater than a threshold concentration chosen in the range of about 25 to about 35 ng/ml.

Méthode pour signaler le début de la phase fertile du cycle d'ovulation humaine, consistant à mesurer en valeur absolue ou relative la concentration d'un composé comme l'estradiol ou un de ses métabolites; si, pendant le cycle en cours, la mesure de la concentration effectuée vers la fin des menstruations révèle une teneur dans un fluide corporel similaire à celle que l'on retrouve dans le même fluide chez une femme normale environ 3 jours avant l'ovulation au cours d'un cycle de 28 jours, le cycle en cours est déclaré immédiatement comme étant dans sa phase fertile. Lorsque le composé analysé est E3G, la mesure de la concentration d'E3G est effectuée au moins une fois pendant les jours 4 à 7 du cycle en cours, en comptant à partir du début des menstruations, et on déclare immédiatement la phase fertile si la mesure d'E3G révèle une concentration égale ou supérieure à la concentration seuil choisie dans une plage de 25 à 35 ng/ml environ.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Monitoring methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monitoring methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monitoring methods will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1599934

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.